arcticbull
People frequently don't realize that thalidomide is a very good chemotherapy drug that's back on the market with the appropriate category X designation.
It treats multiple myeloma, graft-vs-host disease, various HIV associated disease and Kaposi's sarcoma, Leprosy and potentially TB.
The Show NexaCorp Q3 sales box, Slack box and Hex CLI box is half cut off on the right so you can't click the Codex tab, then scrolling down the "vability" which I assume is observability is cut off to the left, and the "adiness" box overlaps "Flexible by design."
Worst of all they committed the cardinal sin of hijacking scrolling. Please for the love of god do not hijack scrolling.
Most people just don't want to deal with it. They want to focus on what they bring to the table and outsource the rest to people who specialize in, own, maintain and support that thing.
It's exceedingly rare for things to go perfectly and as with any other relationship it's how you handle the situation that matters. More people mean more risk that you don't navigate successfully. But of course being the only one means literally everything's on your shoulders and you don't get anyone to bounce ideas off of.
Yes, things going badly creates friction, the question is whether your cofounder relationship helps or hinders, and it sounds like in most cases it hinders. So both can be true.
People don't talk about this overlap but it is real, remember that SBF lead Anthropic's Series B with stolen customer money from the Bahamas. Caroline Ellison participated too, in individual capacity.
https://www.privateequitywire.co.uk/ftx-ceo-leads-580m-serie...
No, in the sense that your therapist is still required to report you to the police in various situations where you pose an immediate threat to yourself or others, etc.
As others have said, it's about perceived brand risk (V/MC allowed X terrible transaction to take place) and regulatory risk.
https://x.com/Gregorein/status/2038953944475472316
Note that Rails was built as a framework for making blogs, I'm having trouble understanding what 78,000 lines of ruby in the context of a Rails blog could ... do.
I'm sure there's some powerful ugly stuff in Office but in a good code that's calcified kind of way. It got that way over like 30 years of releasing to the public across platforms, not over a weekend.
I'd be surprised if microsoft.com is shipping their entire test suite unminified and their back-end posting rich text editor with index.html (with two title tags in the head) and rendering the entire DOM for desktop and mobile regardless of your platform.
I'm not critiquing Garry or the site. I think it's great people are using AI to build things that bring them joy, or that they find useful. I certainly do.
I am opposed to the idea that we've decided to go back to measuring work in terms of lines of code. It has always been the worst metric on earth as a proxy for productivity. Every line is a liability, and it always was. AI has not changed that, if anything it's amplifying it.
The best PRs remove code, not add, and the only companies that seem to have exponentially grown their revenues in line with AI-generated LOC are OpenAI and Anthropic. Everyone else seems to be rummaging around for an ROI.
Good good
The tech everything's-hypergrowth era is, for now, over. Most of the low-hanging fruit that we've collected for the last 20 years of bull market (putting tech into every business) is gone, and companies hired in advance of having the next business to overlay on their current ones. For many that didn't materialize.
I'd love them to index to growth in something other than the number of people in what is otherwise a cost center e.g. revenue. That would help us find out if this is good or, as a cursory read may appear, double-bad.
It would be interesting to compare as you say the median wage change, aggregate wages paid and change in business metrics (ideally revenue and/or profit margins) before and after adoption.
Head count is being used as a proxy here for both business success and employee individual outcomes while they're actually opposed: the business wants less people that they can pay less. The effect shown in the study of AI is that costs grew in two dimensions. I'm not saying it didn't have a positive effect, just that it wasn't measured.
It seems like everyone's trying to have it all ways: AI will lead to more efficiency but also more jobs, more revenue for businesses and more massive bills to pay for the trillion dollars we've put into AI so far. That doesn't... add up. Where's the profit go?
"Help me balance this budget" meme but "oops! all candles."
I feel like we've gone from lines of code in a codebase being a liability, and headcount being bloat, to deploy the slop cannons and load up on cannoneers. I suspect we'll learn... something... I just can't quite put my finger on it. Ah well, who wants to go play with Fable-but-code-gets-generated-by-Opus?
https://www.ecfr.gov/current/title-15/part-772/section-772.1...
On the other end of the spectrum, what doesn’t make sense is testing a random person off the street for Ebola. The prevalence approaches zero and symptoms are fairly noticeable, so any positive test is definitely wrong.
Most diseases are in between and have to be evaluated case by case, not buckshot.
You may be particularly interested to hear that there’s little evidence to support regular checkups in most adults beyond blood pressure testing and cervical cytology.
> Given the lack of favorable evidence and the potential adverse effect, primary care providers should consider the fact that general health checks, beyond the screening interventions shown to have benefit, likely have little or no effect on important health outcomes. Some of the interventions with demonstrated benefit have sufficiently large effects that a uniform application is warranted (blood pressure measurement and cervical cytology screening). In others, the trade‑off between benefits and harms is so close that patients should be involved in fully shared decision making regarding their participation (breast and colon cancer screening).
https://pubmed.ncbi.nlm.nih.gov/31642821/
I suspect your doctor would agree with me. See if they’ll test you for Ebola, for instance. Not because you have symptoms but just cuz.
https://pubmed.ncbi.nlm.nih.gov/31642821/
And blood pressure is especially pernicious, basically every doctors office measures it wrong so the results aren’t particularly useful. Many use the wrong size cuff for example, or don’t give people time to relax before a reading. A ton of people have white coat hypertension, high BP only because they’re in a doctors office.
https://pmc.ncbi.nlm.nih.gov/articles/PMC1120072/
I saw a paper that showed only 36% of cardiologists did it right.
The chance a positive is real is so low you may as well just point to a body part and get it biopsied.
A positive from this kind of test is statistically meaningless.
Bayes Theorem: https://en.wikipedia.org/wiki/Bayes'_theorem
There’s a very good reason we don’t test asymptomatic people in low incidence populations. Basically all positives are false positives when you do that, no matter how accurate the test is.
When you’re testing healthy randos for everything the odds of a positive being false have so many 9s it would make an SRE weep.
Unless this is accurate to a degree previously unheard of in medical science it’s a boondoggle, and I can’t help but notice there’s no mention of accuracy.
Unfortunately that’s just basic statistics.
Biopsies are expensive, waste time, hospital resources and carry risks of infection and scarring that do not net out positively for people who aren’t in your risk group.
This is exactly the case I’m making.
If it has a 1% false positive rate but the incidence is 1%, the vast majority of the positives are false. Then you have to deal with the consequences, including invasive procedures for further diagnosis.
If you’re searching for tens or hundreds of low incidence conditions in the general population at a time it’s absolutely worthless because basically every positive is a false positive. At that point save the scan fee, spin a wheel of body parts and go get a biopsy of that.
This is why doctors are confused why companies are offering periodic full body scans in normal people. They only test people who are high risk or symptomatic to confirm a suspected diagnosis. That extra signal is what makes the test useful.
Go down to the medical diagnosis section for a worked example.
https://en.wikipedia.org/wiki/Bayes'_theorem
Regarding cancers every human has all sorts of weird lumps that are generally meaningless.
In order for this to not be a boondoggle it would have to be spectacularly accurate to a degree previously unheard of. Just from a statistics perspective.